BamSEC and AlphaSense Join Forces
Learn More

MetaVia Inc. – Plans of Reorganization, Merger, Acquisition or Similar

NASDAQ: MTVA    
Share price (6/2/26): $2.71    
Market cap (6/2/26): $14.0 million
Search in Documents
Key Exhibits
External Links

Plans of Reorganization, Merger, Acquisition or Similar Filter

EX-2
from SC 13D/A 8 pages Amended and Restated Voting Agreement
12/34/56
EX-2.1
from 8-K 83 pages Agreement and Plan of Merger by and Among NeuroBo Pharmaceuticals, Inc., Shelby Merger Sub 1, Inc., Shelby Merger Sub 2, LLC, Ana Therapeutics, Inc. and Akash Bakshi, Solely in His Capacity as Stockholder Representative (For the Limited Purposes Described Herein) Dated as of December 31, 2020
12/34/56
EX-2.1
from 425 4 pages First Amendment to Agreement and Plan of Merger and Reorganization
12/34/56
EX-2.1
from 8-K 4 pages First Amendment to Agreement and Plan of Merger and Reorganization
12/34/56
EX-2.5
from 425 6 pages Lock-Up Agreement July , 2019
12/34/56
EX-2.5
from 8-K 6 pages Lock-Up Agreement July , 2019
12/34/56
EX-2.4
from 8-K 13 pages Voting Agreement
12/34/56
EX-2.4
from 425 13 pages Voting Agreement
12/34/56
EX-2.3
from 425 12 pages Voting Agreement
12/34/56
EX-2.3
from 8-K 12 pages Voting Agreement
12/34/56
EX-2.2
from 8-K 22 pages Contingent Value Rights Agreement
12/34/56
EX-2.2
from 425 22 pages Contingent Value Rights Agreement
12/34/56
EX-2.1
from 425 101 pages Agreement and Plan of Merger and Reorganization Among: Gemphire Therapeutics Inc., a Delaware Corporation; Gr Merger Sub Inc., a Delaware Corporation; and NeuroBo Pharmaceuticals, Inc., a Delaware Corporation Dated as of July 24, 2019
12/34/56
EX-2.1
from 8-K 101 pages Agreement and Plan of Merger and Reorganization Among: Gemphire Therapeutics Inc., a Delaware Corporation; Gr Merger Sub Inc., a Delaware Corporation; and NeuroBo Pharmaceuticals, Inc., a Delaware Corporation Dated as of July 24, 2019
12/34/56